Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News NantHealth Inc NHIQ

Healthcare Medical Devices
NantHealth, Inc. provides enterprise solutions that help businesses transform complex data into actionable insights. The Company is engaged in offering ways to move, interpret, and visualize complex and highly sensitive information to its customers in the healthcare, life sciences, logistics, telecommunications, and other industries to automate, understand, and act on data while keeping it... see more

Recent & Breaking News (PINL:NHIQ)

NantHealth and NantOmics Present Four Research Papers Demonstrating Advancements in Cancer Diagnostics with NantHealth’s GPS Cancer® and Liquid GPS™

Business Wire October 29, 2018

NantHealth Announces Appointment of Two Senior Executives to Lead Strategy, Business Development, and Global Sales

Business Wire September 7, 2018

Using the Technology That Powers GPS Cancer™, Scientists Have Developed Fresh Insights into the Driving Mechanisms of a Rare Skin Cancer

Business Wire August 27, 2018

Consolidated Research: 2018 Summary Expectations for GSV Capital, NantHealth, Gold Fields, Sogou Inc. Sponsored ADR, Clementia Pharmaceuticals, and Arbutus Biopharma — Fundamental Analysis, Key Performance Indications

GlobeNewswire August 21, 2018

NantHealth Reports 2018 Second-Quarter Financial Results

Business Wire August 9, 2018

NantHealth to Report 2018 Second-Quarter Financial Results and Host Conference Call on Thursday, August 9

Business Wire August 3, 2018

SHAREHOLDER ALERT: Hynes Keller & Hernandez, LLC Announces Investigation of NantHealth, Inc. (NH) and FleetCor Technologies, Inc. (FLT)

PR Newswire July 31, 2018

NantHealth Unveils New Collaboration Tools - Provider Initiated Document Exchange and Authorization Appeals

Business Wire June 20, 2018

NantHealth to Present and Exhibit on the Convergence of Precision Medicine and Value-Based Care at America’s Health Insurance Plans (AHIP) Institute & Expo 2018

Business Wire June 19, 2018

New Research Coverage Highlights Materialise NV, MacroGenics, GasLog Partners LP, TCP Capital, NantHealth, and Net 1 UEPS Technologies — Consolidated Revenues, Company Growth, and Expectations for 2018

GlobeNewswire June 6, 2018

NantHealth and NantOmics to Present Data on the Frequency of Non-Expressed Variants Tested by Standard NGS Panel at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting

Business Wire June 2, 2018

NantHealth and NantOmics to Present Patterns of Immune Checkpoint Molecules in Relation to PD-L1 Expression at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting

Business Wire June 2, 2018

NantHealth and NantOmics to Present Data on Three-Fold Overestimation of Tumor Mutation Burden Using Gene Panel vs Whole Exome at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting

Business Wire June 2, 2018

NantHealth and NantOmics to Share Data on Next-Generation Sequencing of Paired DNA and RNA Analysis of Rare Tumors at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting

Business Wire June 2, 2018

NantHealth Unveils Liquid GPS™, Powerful Next-Generation Tool for Blood-Based Tumor Profiling and Quantitative Monitoring

Business Wire June 2, 2018

NantHealth to Present at the Jefferies 2018 Global Healthcare Conference on June 6

Business Wire May 30, 2018

NantOmics Announces Study Showing Signature Analysis That Reveals Three Distinct Classifications of Skin Cancer Known as Sebaceous Carcinoma

Business Wire May 21, 2018

NantHealth to Present at the Bank of America Merrill Lynch Health Care Conference 2018 on May 17

Business Wire May 17, 2018

NantHealth Showcases and Presents Its Portfolio of Medical Device Integration (MDI) Products to Provide Current and Future Insights to Patient Care at the Largest E-Health Event in Scandinavia

Business Wire May 14, 2018

The Shuman Law Firm Investigates NantHealth, Inc.

Business Wire May 14, 2018